P75 neurotrophin receptor in the nucleus basalis of Meynert in relation to age, sex, and Alzheimer's disease

Experimental Neurology

Volumn 161, Issue 1, 2000, Pages 245-258

  Salehi, Ahmad ^a   Ocampo, Marta ^a   Verhaagen, Joost ^a   Swaab, Dick F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Aging; Alzheimer's disease; Antigen retrieval; Menopause; Neurotrophins; NGF; Nucleus basalis; p75 receptor; Sex; Trk receptors

Indexed keywords

NEUROTROPHIN RECEPTOR; PROTEIN P75;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE;

EID: 0034054499     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7252     Document Type: Article

References (92)

1. Appel L. S. H. Unifying hypothesis for cause of amyotrophic lateral sclerosis, Parkinson and Alzheimer's disease. Ann. Neurol. 10:1981;499-505.
2. Arendt T., Bruckner M. K., Krell T., Pagliusi S., Kruska L., Heumann R. Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury. II. Reactive expression of the nerve growth factor gene in astrocytes. Neuroscience. 65:1995;647-659.
3. Arendt T., Schindler C., Brückner M. K., Eschrich K., Bigl V., Zedlick D., Marcova L. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 allele. J. Neurosci. 15:1997;516-529.
4. Blurton-Jones M. M., Roberts J. A., Tuszynski M. H. Estrogen receptor immunoreactivity in the adult primate brain: Neuronal distribution and association with p75, trkA, and choline acetyltransferase. J. Comp. Neurol. 405:1999;529-542.
5. Boissiere F., Hunot S., Faucheux B., Hersh L. B., Agid Y., Hirsch E. C. Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 8:1997;1-8.
6. Boissiere F., Faucheux B., Ruberg M., Agid Y., Hirsch E. C. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Exp. Neurol. 145:1997;245-252.
7. Brayne C., Gill C., Huppert F. A., Barkley C., Gehlhaar E., Girling D. M., Paykel E. S. Incidence of clinically diagnosed subtypes of dementia in an elderly population: Cambridge Project for Later Life. Br. J. Psychiatry. 167:1995;255-262.
8. Butcher L. L., Woolf N. J. Neurotrophic agents may exacerbate the pathologic cascade of Alzheimer's disease. Neurobiol. Aging. 10:1989;557-570.
9. Chao M. V. Neurotrophin receptors: A window into neuronal differentiation. Neuron. 9:1992;583-593.
10. Crucher K. A., Scott S. A., Liang S., Everson W. V., Weingartner J. Detection of NGF-like activity in human brain tissue: Increased levels in Alzheimer's disease. J. Neurosci. 13:1993;2540-2550.
11. Curtis R., Adryan K. M., Stark J. L., Park J. S., Compton D. L., Weskamp G. Differential role of the low affinity neurotrophin receptors (p75) in retrograde axonal transport of the neurotrophins. Neuron. 14:1995;1201-1211.
12. Ehlers M. D., Kaplan D. R., Price D. L., Koliatsos V. E. NGF-stimulated retrograde transport of trkA in the mammalian nervous system. Cell. Biol. 130:1995;149-156.
13. Etienne P., Robitaille Y., Wood P., Gauthier S., Nair N. P. V., Quirion R. Nucleus basalis neuronal loss, neuritic plaque and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience. 19:1986;1279-1291.
14. Fratiglioni L., Viitanen M., Vonstrauss E., Winblad B. Late-onset Alzheimer's disease: Incidence data from the Kungsholmen project, Stockholm. Iqbal K., Winblad B., Nishimura T., Takeda M., Wisniewski H. M. Alzheimer's Disease: Biology, Diagnosis and Therapeutics. 1997;49-53 Wiley, New York.
15. Garver T. D., Oyler G. A., Harris K. A., Polavarapu R., Damuni Z., Lehman R. A., Billingsley M. L. Tau phosphorylation in brain slices: Pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase. Mol. Pharmacol. 47:1995;745-756.
16. Gnahn H., Hefti F., Heumann R., Schwab M. E., Thoenen H. NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: Evidence for a physiological role of NGF in the brain. Brain Res. 285:1983;45-52.
17. Goedert M., Fine A., Hunt S. P., Ullrich A. Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. Mol. Brain Res. 1:1986;85-92.
18. Goedert M., Fine A., Dawbarn D., Wilcock G. K., Chao M. V. Nerve growth factor receptor mRNA distribution in human brain: Normal levels in basal forebrain in Alzheimer's disease. Mol. Brain Res. 5:1989;1-7.
19. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons of the fimbrial transection. J. Neurosci. 6:1986;2155-2162.
20. Hefti F., Weiner W. J. Nerve growth factor and Alzheimer's disease. Ann. Neurol. 20:1986;275-281.
21. Hefti F., Mash D. F. Localization of NGF receptors in the normal brain and in Alzheimer's disease. Neurobiol. Aging. 10:1989;75-87.
22. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25:1994;1418-1435.
23. Hempstead B. L., Martin-Zanca D., Kaplan D. R., Parada L. F., Chao M. V. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature. 350:1991;678-683.
24. Higgins G. A., Mufson E. J. NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease. Exp. Neurol. 106:1989;222-236.
25. Holtzman D. M., Li Y. W., Gage F. H., DeArmond S. J., Epstein C. J., McKinley M. P., Mobley W. C. Modeling cholinergic abnormalities in Down syndrome and Alzheimer's disease. Prog. Clin. Biol. Res. 373:1991;189-202.
26. Holtzman D. M., Li Y., Chen K., Gage F. H., Epstein C. J., Mobley W. C. Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration. Neurology. 43:1993;2668-2673.
27. Holtzman D. M., Mobley W. C. Neurotrophic factors and neurologic disease. West J. Med. 161:1994;246-254.
28. Honjo H., Ogino Y., Naitoh K., Urabe M., Kitawaki J., Yasuda J., Yamamoto T. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type). J. Steroid Biochem. 34:1989;521-525.
29. Ip N. Y., Stitt T. N., Tapley P., Klein R., Glass D. J., Fandl J. Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron. 10:1993;137-149.
30. Kaplan D. R., Martin-Zanca D., Parada L. F. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature. 350:1991;158-160.
31. Kaplan D. R., Hempstead B. L., Martine-Zanca D., Chao M. V., Parada L. F. The trk proto-oncogene product: a signal transducting receptor for nerve growth factor. Science. 252:1991;554-558.
32. Katzman R. The prevalence and malignancy of Alzheimer's disease. Arch. Neurol. 33:1976;217-218.
33. Klein R., Nanduri V., Jing S., Lamballe F., Tapley P., Bryant S. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell. 66:1991;395-403.
34. Klein R., Smeyne R. J., Wurst W., Long L. K., Auerbach B. A., Joyner A. L. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell. 75:1993;113-132.
35. Klein R., Silos-Santiago I., Smeyne R. J., Lira S. A., Brambilla R., Bryant S. Disruption of the neurotrophin-3 receptor gene trkC eliminates Ia muscle afferents and results in abnormal movements. Nature. 368:1994;249-251.
36. Kerwin J. M., Morris C. M., Perry R. H., Perry E. K. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease. Neurosci. Lett. 143:1992;101-104.
37. Kojima M., Takahashi N., Ikeuchi T., Hatanaka H. Nerve growth factor (NGF)-mediated up-regulation of low-affinity NGF receptor gene expression in cultured basal forebrain cholinergic neurons from postnatal 3-day-old rats. Mol. Brain Res. 16:1992;267-273.
38. Kordower J. H., Gash D. M., Bothwell M., Hersh L., Mufson E. J. Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer's patients. Neurobiol. Aging. 10:1989;67-74.
39. Korsching S., Auburger G., Heumann R., Scott J., Theonen H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlates with cholinergic innervation. EMBO J. 4:1985;1389-1393.
40. Loetscher H., Pan Y. C., Lahm H. W., Gentz R., Brockhaus M., Tabuchi H., Lesslauer W. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61:1990;351-359.
41. Loy R., Lachyankar M. B., Condon P. J., Poluha D. K., Ross A. H. Retrograde axonal transport and lesion-induced upregulation of the TrkA high-affinity NGF receptor. Exp. Neurol. 130:1994;377-386.
42. MacMahon S. B., Armanini M. P., Ling L. H., Phillips H. S. Expression and coexpression of trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron. 12:1994;1161-1171.
43. Majdan M., Lachance C., Gloster A., Aloyz R., Zeindler C., Bamji S. Transgenic mice expressing the intracellular domain of the p75 neurotrophin receptor undergo neuronal apoptosis. J. Neurosci. 17:1997;6988-6998.
44. Mandel R. J., Gage F. H., Clevenger D. G., Spratt S. K., Snyder R. O., Leff S. E. Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration. Exp. Neurol. 155:1999;59-64.
45. Marano N., Dietzschold B., Earley J. J., Schatteman G., Thompson S., Grob P. Purification and amino terminal sequencing of human melanoma nerve growth factor receptor. J. Neurochem. 48:1987;225-232.
46. Martinez-Serrano A., Hantzopoulos P. A., Bjorklund A. Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: neurotrophic effects on cholinergic neurons. Eur. J. Neurosci. 8:1996;727-735.
47. Marx J. NGF and Alzheimer's: Hopes and fears. Science. 26:1990;408-410.
48. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease: Report of NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
49. McMillan P. J., Singer C. A., Dorsa D. M. The effects of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague-Dawley rat. J. Neurosci. 16:1996;1860-1865.
50. Mesulam M.-M., Van Hoesen G. W. Acetyl cholinesterase projections from the basal forebrain of the rhesus monkey to neocortex. Brain Res. 109:1976;152-157.
51. Mesulam M.-M., Mufson E. J., Levey A. I., Wainer B. H. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in the rhesus monkey. J. Comp. Neurol. 214:1983;170-197.
52. Mobley W. C., Rutkowski J. L., Tennekoon G. L., Gemski J., Buchanan K., Johnston M. V. Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Brain Res. 387:1986;53-62.
53. Mobley W. C., Neve R. L., Prusiner S. B., McKinley M. P. Nerve growth factor increases mRNA levels for the prion protein and the β-amyloid protein precursor in developing hamster brain. Proc. Natl. Acad. Sci. USA. 85:1988;9811-9815.
54. Mufson E. J., Bothwell M., Kordower J. H. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain. Exp. Neurol. 105:1989;221-232.
55. Mufson E. J., Bothwell M., Hersh L. B., Kordower J. H. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: Colocalization with cholinergic neurons. J. Comp. Neurol. 8:1989;196-217.
56. Mufson E. J., Presley L. N., Kordower J. H. Nerve growth factor receptor immunoreactivity within nucleus basalis (ch4) in Parkinson's disease: Reduced cell numbers and colocalization with cholinergic neurons. Brain Res. 539:1991;19-30.
57. Mufson E. J., Brashers-Krug T., Kordower J. H. p75 nerve growth factor receptor immunoreactivity in the human brainstem and spinal cord. Brain Res. 589:1992;115-123.
58. Mufson E. J., Kordower J. H. Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 89:1992;569-573.
59. Mufson E. J., Conner J. M., Kordower J. H. Nerve growth factor in Alzheimer's disease: Defective retrograde transport to nucleus basalis. Neuroreport. 6:1995;1063-1066.
60. Mufson E. J., Li J. M., Sobreviela T., Kordower J. H. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. Neuroreport. 20:1996;25-29.
61. Mufson E. J., Lavine N., Jaffar S., Kordower J. H., Quirion R., Saragovi H. U. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp. Neurol. 146:1997;91-103.
62. Mufson E. J., Kroin J. S., Sendera T. J., Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 57:1999;451-484.
63. Nordberg A. Functional studies of new drugs for the treatment of Alzheimer's disease. Acta Neurol. Scand. Suppl. 165:1996;137-141.
64. Oehm A., Behrmann I., Falk W., Pawlita M., Maier G., Klas C. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: Sequence identity with the Fas antigen. J. Biol. Chem. 267:1992;10709-10715.
65. Paganini-Hill A., Henderson V. W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140:1994;256-261.
66. Paganini-Hill A., Henderson V. W. Estrogen replacement therapy and risk of Alzheimer disease. Arch. Intern. Med. 28:1996;2213-2217.
67. Prelevic G. M., Jacobs H. S. Menopause and post-menopause. Bailliere's Clin. Endocrinol. Metab. 11:1997;311-340.
68. Rabizadeh S., Oh J., Zhong L. T., Yang J., Bitler C. M., Butcher L. L., Bredesen D. E. Induction of apoptosis by the low-affinity NGF receptor. Science. 261:1993;345-348.
69. Rebeck G. W., Hyman B. T. Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease. Neurobiol. Aging. 14:1993;45-47.
70. Reisberg B., Ferris B., DeLeon M. J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry. 139:1982;1136-1139.
71. Riccio A., Pierchala B. A., Ciarallo C. L., Ginty D. D. An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons. Science. 277:1997;1097-1100.
72. Salehi A., Lucassen P. J., Pool C. W., Gonatas N. K., Ravid R., Swaab D. F. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience. 4:1994;871-880.
73. Salehi A., Verhaagen J., Dijkhuizen P. A., Swaab D. F. Colocalization of high affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience. 75:1996;373-387.
74. Salehi A., Verhaagen J., Swaab D. F. Van Leeuwen F. W., Salehi A., Giger R. J., Holtmaat A. J. G. D., Verhaagen J. Neurotrophin receptors in Alzheimer's disease - Neuronal regeneration and regeneration: From Basic Mechanisms to Prospects for Therapy. 1998;71-89 Elsevier, Amsterdam.
75. Salehi A., Gonzalez-Martinez V., Swaab D. F. A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiol. Aging. 19:1999;505-510.
76. Scott S. A., Mufson E. J., Weingartner J. A., Skau K. A., Crutcher K. A. Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis. J. Neurosci. 15:1995;6213-6221.
77. Seiger Å., Nordberg A., Von Holst H., Bäckman L., Ebendal T., Alafuzoff I. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: The first attempt of a possible future treatment strategy. Behav. Brain Res. 57:1993;255-261.
78. Seiler M., Schwab M. E. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res. 300:1984;33-39.
79. Shelton D. L., Reichart L. F. Studies on the expression of the β nerve growth factor (NGF) gene in the central nervous system: Levels and regional distribution of NGF mRNA suggest that NGF function as a trophic factor for several distinct populations of neurons. Proc. Natl. Acad. Sci. USA. 83:1986;2714-2718.
80. Shi S. R., Cote R. J., Taylor C. R. Antigen retrieval immunohistochemistry: Past, present, and future. J. Histochem. Cytochem. 45:1997;327-343.
81. Sofroniew M. V., Galletly N. P., Isacson O., Svendsen C. N. Survival of adult basal forebrain cholinergic neurons after loss of target neurons. Science. 247:1990;338-342.
82. Sohrabji F., Greene L. A., Miranda R. C., Toran-Allerand C. D. Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J. Neurobiol. 25:1994;974-988.
83. Sohrabji F., Miranda R. C., Toran-Allerand C. D. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J. Neurosci. 14:1994;459-471.
84. Swaab D. F., Lucassen P. J., Salehi A., Scherder E. J., van Someren E. J., Verwer R. W. Reduced neuronal activity and reactivation in Alzheimer's disease. Van Leeuwen F. W., Salehi A., Giger R. J., Holtmaat A. J. G. D., Verhaagen J. Neuronal regeneration and regeneration: From Basic Mechanisms to Prospects for Therapy. 1998;343-377 Elsevier, Amsterdam.
85. Taniuchi M., Schweitzer J. B., Johnson E. M. Jr. Nerve growth factor receptor molecules in rat brain. Proc. Natl. Acad. Sci. USA. 83:1986;1950-1954.
86. Toran-Allerand C. D. The estrogen/neurotrophin connection during neural development: Is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant. Dev. Neurosci. 18:1996;36-48.
87. Treanor J. J., Dawbarn D., Allen S. J., MacGowan S. H., Wilcock G. K. Low affinity nerve growth factor receptor binding in normal and Alzheimer's disease basal forebrain. Neurosci. Lett. 121:1991;73-76.
88. Van der Zee C. E., Ross G. M., Riopelle R. J., Hagg T. Survival of cholinergic forebrain neurons in developing p75NGFR-deficient mice. Science. 274:1996;1729-1732.
89. Venero J. L., Hefti F., Beck K. D. Retrograde transport of nerve growth factor from hippocampus and amygdala to trkA messenger RNA expressing neurons in paraventricular and reuniens nuclei of the thalamus. Neuroscience. 64:1995;855-860.
90. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., Delong M. R. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science. 215:1981;1237-1239.
91. Williams L. R., Varon S., Peterson G. M., Wictorin K., Fischer W., Bjorklund A., Gage F. H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. USA. 83:1986;9231-9235.
92. Winkler J., Thal L. J. Clinical potential of growth factors in neurological disorders. CNS Drugs. 2:1994;465-478.